• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用统计实验设计优化阿托伐他汀钙固化胶束制剂以提高口服生物利用度。

Optimization of a solidified micelle formulation for enhanced oral bioavailability of atorvastatin calcium using statistical experimental design.

机构信息

College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.

Department of Psychology, York University, Toronto, Ontario, Canada.

出版信息

Pharm Dev Technol. 2023 Jun;28(5):479-491. doi: 10.1080/10837450.2023.2208206. Epub 2023 May 5.

DOI:10.1080/10837450.2023.2208206
PMID:37099663
Abstract

To enhance the oral bioavailability of atorvastatin calcium (ATV), a novel solidified micelle (S-micelle) was developed. Two surfactants, Gelucire 48/16 (G48) and Tween 20 (T20), were employed for micelle formation, and two solid carriers (SC), Florite PS-10 (FLO) and Vivapur 105 (VP105), were selected as solid carriers. The S-micelle was optimized using a Box-Behnken design with three independent variables, including G48:T20 (, 1.8:1), SC:G48 + T20 (, 0.65:1), and FLO:VP105 (, 1.4:0.6), resulting in a droplet size () of 198.4 nm, dissolution efficiency at 15 min in the pH 1.2 medium () of 47.6%, Carr's index () of 16.9, and total quantity () of 562.5 mg. The optimized S-micelle resulted in good correlation showing percentage prediction values less than 10%. The optimized S-micelle formed a nanosized dispersion in the aqueous phase, with a higher dissolution rate than raw ATV and crushed Lipitor®. The optimized S-micelle improved the relative bioavailability of oral ATV (25 mg equivalent/kg) in rats by approximately 509 and 271% compared to raw ATV and crushed Lipitor, respectively. In conclusion, the optimized S-micelle possesses great potential for the development of solidified formulations for improved oral absorption of poorly water-soluble drugs.

摘要

为了提高阿托伐他汀钙(ATV)的口服生物利用度,开发了一种新型固态胶束(S-胶束)。使用两种表面活性剂,Gelucire 48/16(G48)和吐温 20(T20)形成胶束,选择两种固体载体(SC),Florite PS-10(FLO)和 Vivapur 105(VP105)作为固体载体。使用三因素 Box-Behnken 设计优化 S-胶束,包括 G48:T20(,1.8:1)、SC:G48+T20(,0.65:1)和 FLO:VP105(,1.4:0.6),结果粒径()为 198.4nm,在 pH 1.2 介质中 15 分钟的溶解效率()为 47.6%,Carr 指数()为 16.9%,总量()为 562.5mg。优化后的 S-胶束显示出良好的相关性,预测值百分比小于 10%。优化后的 S-胶束在水相中成纳米分散体,比原 ATV 和粉碎的 Lipitor®具有更高的溶解速率。与原 ATV 和粉碎的 Lipitor 相比,优化后的 S-胶束使口服 ATV(25mg 当量/kg)的相对生物利用度在大鼠中分别提高了约 509%和 271%。总之,优化后的 S-胶束为改善难溶性药物的口服吸收而开发固态制剂具有很大的潜力。

相似文献

1
Optimization of a solidified micelle formulation for enhanced oral bioavailability of atorvastatin calcium using statistical experimental design.应用统计实验设计优化阿托伐他汀钙固化胶束制剂以提高口服生物利用度。
Pharm Dev Technol. 2023 Jun;28(5):479-491. doi: 10.1080/10837450.2023.2208206. Epub 2023 May 5.
2
Development of a Solid Supersaturable Micelle of Revaprazan for Improved Dissolution and Oral Bioavailability Using Box-Behnken Design.采用 Box-Behnken 设计开发雷贝拉唑固体超饱和胶束以提高溶解和口服生物利用度。
Int J Nanomedicine. 2021 Feb 17;16:1245-1259. doi: 10.2147/IJN.S298450. eCollection 2021.
3
Optimization of solid self-dispersing micelle for enhancing dissolution and oral bioavailability of valsartan using Box-Behnken design.采用 Box-Behnken 设计优化固体自分散胶束以提高缬沙坦的溶解和口服生物利用度。
Int J Pharm. 2020 Jul 30;585:119483. doi: 10.1016/j.ijpharm.2020.119483. Epub 2020 May 30.
4
Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability.开发一种用于阿托伐他汀钙的固化自微乳化药物递送系统(S-SMEDDS),以提高其溶出度和生物利用度。
Int J Pharm. 2016 Jun 15;506(1-2):302-11. doi: 10.1016/j.ijpharm.2016.04.059. Epub 2016 Apr 25.
5
Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.采用D-最优混合设计法开发并优化阿托伐他汀钙自微乳化药物递送系统
Int J Nanomedicine. 2015 Jun 5;10:3865-77. doi: 10.2147/IJN.S83520. eCollection 2015.
6
Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.基于 Gelucire®的阿托伐他汀钙固体分散体的配方:体外溶出度和体内生物利用度研究。
AAPS PharmSciTech. 2021 May 24;22(5):161. doi: 10.1208/s12249-021-02019-5.
7
Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.Box-Behnken 设计在理解染料木黄酮自微乳给药系统质量及其制剂优化中的应用。
Pharm Dev Technol. 2009;14(6):642-9. doi: 10.3109/10837450902882385.
8
Statistical approach for solidifying ticagrelor loaded self-microemulsifying drug delivery system with enhanced dissolution and oral bioavailability.统计学方法用于固化替格瑞洛自微乳药物传递系统,以提高其溶解性能和口服生物利用度。
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109980. doi: 10.1016/j.msec.2019.109980. Epub 2019 Jul 16.
9
Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function.采用 Box-Behnken 设计和可满意度函数优化替米沙坦自微乳给药系统。
J Pharm Pharmacol. 2013 Oct;65(10):1440-50. doi: 10.1111/jphp.12115. Epub 2013 Jul 24.
10
Optimization of Nanostructured Lipid Carriers of Fenofibrate Using a Box-Behnken Design for Oral Bioavailability Enhancement.采用 Box-Behnken 设计优化非诺贝特纳米结构脂质载体以提高口服生物利用度。
Curr Drug Deliv. 2022;19(7):773-787. doi: 10.2174/1567201818666210423110745.